KD
Kieran Docherty
University of Glasgow
Research areas: Medicine · Cardiology and Cardiovascular Medicine · Heart Failure Treatment and Management · Cardiovascular Function and Risk Factors · Diabetes Treatment and Management
0000-0002-5446-9969
Employment
-
University of Glasgow Clinical Research Fellow2018 - Present
Education
Education history is unavailable.
Projects & Funding
-
The effects of sacubitril/valsartan compared to valsartan on left ventricular remodelling in patients with asymptomatic left ventricular systolic dysfunction after myocardial infarction: a randomized, double blinded active-comparator cardiac-MR based tri… British Heart Foundation
Publications (116)
- Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial. Save
- A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. Save
- Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Save
- Recent successes in heart failure treatment. Save
- Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Save
- Natriuretic Peptides Improve Classification of People at Low Risk of Atrial Fibrillation after Stroke Save
- Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Save
- SGLT2 Inhibitors and Iron: More Than Meets the Eye. Save
- The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF. Save
- Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Save
- Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials. Save
- Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Save
- Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure. Save
- Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016. Save
- Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Save
- Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction. Save
- Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HF. Save
- Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. Save
- Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance? Save
- Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER. Save